Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/01/2003US20030082763 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082762 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082761 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082760 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082759 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082758 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors
05/01/2003US20030082757 Polypeptide for use in the treatment and prevention of diabetes, obesity, cancer, infections, metabolic, nervous system, immunological, blood disorders
05/01/2003US20030082754 Delta4 - desaturase genes and uses thereof
05/01/2003US20030082749 Fc fusion proteins of human erythropoietin with increased biological activities
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082745 Tumor necrosis-factor inducible promoter for use as tool in the treatment of cancer and autoimmune diseases
05/01/2003US20030082744 Binding protein for use in as diagnostic tool in human therapeutics
05/01/2003US20030082740 Antitumor agent for use in the treatment of cancer
05/01/2003US20030082737 Nucleotide sequences coding polypeptide for use in the eating disorders
05/01/2003US20030082736 Nucleotide sequences coding polypeptide for use in the treatment of cachexia, sepsis, arthritis, diabetes, multiple sclerosis, fibrosis, cerebral, allograft and xenograft disorders
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082721 Transgenic animals expressing androgen receptor complex-associated protein
05/01/2003US20030082720 Compositions methods and kits relating to treating and diagnosing hypertension
05/01/2003US20030082714 Novel nucleic acid and polypeptide
05/01/2003US20030082712 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082711 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082710 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082708 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082706 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082705 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082704 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082703 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082702 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders
05/01/2003US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082685 Chemotherapeutic induction of egr-1 promoter activity
05/01/2003US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
05/01/2003US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
05/01/2003US20030082681 Nucleic acids, proteins, and antibodies
05/01/2003US20030082680 Candida albicans gene, integrin-like protein, antibodies, and methods of use
05/01/2003US20030082678 Methods and compositions for regulating body weight in bovine species
05/01/2003US20030082677 Nucleotide sequences coding polypeptide for use in the treatment of glucose transport defects
05/01/2003US20030082675 Expression vector for use as gene therapeutic tool
05/01/2003US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders
05/01/2003US20030082672 Dna encoding galanin galr2 receptors and uses thereof
05/01/2003US20030082670 Platelet-derived growth factor C, DNA coding therefor, and uses thereof
05/01/2003US20030082653 Protein for use in the treatment and diagnosis of cancer
05/01/2003US20030082651 Notch receptor agonists and uses
05/01/2003US20030082650 Great gene and protein
05/01/2003US20030082647 Transporter protein
05/01/2003US20030082646 Antigenic targets of autoimmune sensorineural hearing loss (AISNHL) and development of tests for diagnosis and management of AISNHL
05/01/2003US20030082645 Nervous system agent for use in the treatment of psychological disorders
05/01/2003US20030082641 A method of treating depression using a galr3 receptor antagonist
05/01/2003US20030082638 Methods for screening osteogenic compounds
05/01/2003US20030082636 Antibody for use as tool in the treatment of blood disorders
05/01/2003US20030082629 Screening methods for compounds useful in the regulation of cell proliferation
05/01/2003US20030082628 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer and nervous system disorders
05/01/2003US20030082627 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082622 Crystalline polypeptide for use in the treatment of tumor and cardiovascular and respiratory system disorders
05/01/2003US20030082621 Fucose containing proteoglycan or acidic glycan and their pharmaceutical use
05/01/2003US20030082620 Novel human genes and gene expression products: II
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082603 Colon cancer marker
05/01/2003US20030082586 Antibody for use in the diagnosis and treatment of brain tumors, alzhemier's and brain developmental disorders
05/01/2003US20030082575 Translation system for use in the generation of protein containing adjusted amino acid sequences
05/01/2003US20030082574 Polyvalent cation-sensing receptor in atlantic salmon
05/01/2003US20030082573 Cell cycle protein
05/01/2003US20030082556 Binary encoded sequence tags
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082542 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082541 Nucleotide sequences coding polypeptide for use in the treatment of skin disorders and cancer
05/01/2003US20030082540 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030082532 Tumor necrosis factor receptor related gene 12 polypeptides
05/01/2003US20030082527 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor
05/01/2003US20030082526 Diagnosis and treatment of cancer
05/01/2003US20030082525 Five-Helix protein
05/01/2003US20030082523 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
05/01/2003US20030082517 Treating viral disease in mammals; administer viricide to mammal, monitor activity of virus, reduced viral activity indicates effective viricide
05/01/2003US20030082515 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator
05/01/2003US20030082240 Porous sphere of calcium carbonate
05/01/2003US20030082234 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
05/01/2003US20030082233 Method and composition for modulating bone growth
05/01/2003US20030082224 Antitumor, anticancer agents
05/01/2003US20030082202 Tryparedoxin, expression plasmid, process of production, method of use, test kit, and pharmaceutical composition
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082196 Anticancer agents
05/01/2003US20030082195 Method of enhancing an immune response
05/01/2003US20030082194 Inducting immunology response; anticancer agent
05/01/2003US20030082193 Immunoassay using computer; forming vaccine, immunoglobulins
1 ... 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 ... 3163